3.19.21
6 min. Read

That weird FDA de-regulatory notice.

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health. Thanks to everyone who sent over names of digital health startups that spun out of pharmaceutical companies. (I received a lot of emails.) Working on a round-up of those for next week, so hit reply if you think I might be missing any.

 E&O Fridays.

OK, here's what's happening this week in the world of pharma digital products and FDA-regulated digital health:

  • The big hire this week goes to Amalgam Rx, which just announced that the COO of CMS, Jennifer Main, will join the company next month as its COO and CFO.
  • Meanwhile, investment dollars continue to flow: Happify Health announced a sizeable $73 million Series D led by Deerfield Management Company.
  • The big product launch this week goes to AstraZeneca, which officially 
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
UnitedHealth’s employee benefits. Omada signals IPO. Detailed Spring Health pricing.
11.21.23
9 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
11.16.23
8 min. Read
Lyra Health pricing. Spring Health signals IPO.
11.09.23
6 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
11.06.23
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
10.27.23
5 min. Read
CPT decisions. Trials: Big Health, Mahana and more
10.20.23
6 min. Read
Teladoc quietly bought MSK startup. Omada hits 1M milestone.
10.13.23
5 min. Read
Akili CEO steps down. Aetna rolls back some virtual care coverage
10.06.23
5 min. Read
Biogen cuts digital, MedRhythms, Apple. Pfizer on PDTs.
9.29.23
6 min. Read
CMS: PDTs have potential. Trials: Big, Koko, GAIA
9.22.23
6 min. Read
  • First
  • Previous
  • 1 of 35
  • Next
  • Last